PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pharmacist computer imageSeptember 21 2017

Pharmacy IT systems supplier Cegedim has announced it has commenced beta testing of Pharmacy Manager version 10.3. The new version has specific functionalities for England and Scotland. 

 For systems in England, new functionality includes:

  • making all aspects of Pharmacy Manager compatible with Windows 10 and 64 bit processing;
  • improved speed and stability for the patient details report;
  • Healthi Services MUR integration, minimising duplication and utilising a streamlined workflow for medicines use reviews.

For Scottish systems, new functionality includes:

  • Universal claim framework (UCF) functionality, removing the need to handwrite and transcribe the dispensing event onto the community pharmacy unscheduled care (CPUS) form;
  • the national MAR chart;
  • two new endorsements, MIL and BAN (manufacturer/importer license number and batch number of an unlicensed medicine)
  • unlicensed products – fixed handling costs, making claiming easier
  • improved speed and stability of the patient details report

Last month, Cegedim launched Version 9.3 of Nexphase. New functionality includes:

  • EPS release 2 claim amendments –allowing users to edit prescriptions and send amended dispenses and/or claim notifications;
  • optional printing of the repeat medication re-order form;
  • dispensing compliance changes – updates to EPS release 2 nominated downloads, reimbursement submission reminder and owings expiry date.

Links:
Cegedim Pharmacy manager announcement        
Cegedim Nexphase announcement          

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...